FDA requires opioid manufacturers to update prescribing information
5

FDA requires opioid manufacturers to update prescribing information

While some progress has been made, the opioid crisis continues to be a serious public health challenge.

Opioids are responsible for the overwhelming majority of overdose deaths in recent years. The Food and Drug Administration (FDA) has taken an additional step to further emphasize and characterize risks of long-term opioid use by requiring manufacturers to update their prescribing information. What changes are being made and what can your facility do to keep patients safe?

In this week’s client newsletter, we discussed the labeling changes the FDA is requiring. We also address what the safety concerns are, the specific changes the FDA is asking for, as well as what prescribers and patients should consider. If you have any questions about these changes, or want to discuss patient safety, please contact us.

The Consultant Pharmacists at OctariusRx provide guidance on safe medication management, survey readiness and cost savings to ambulatory healthcare facilities/surgery centers, senior care facilities and pharmacies. We also help individual patients optimize their medications to improve their quality of life and save money. Contact us for assistance.

Any health, medical or drug information on the Web Site is for informational purposes only. This information is not intended to be used, and you should not use it, as a substitute for obtaining professional healthcare advice, diagnosis or treatment. You should always seek the advice of your doctor, a pharmacist or other qualified healthcare provider for professional healthcare advice, diagnosis or treatment for any medical condition.